• About
    Our Story Honorary President Big Issue Team Consultants
  • Investment
    Stretagies Portfolio
  • Pharmacetical
  • Corporate Governance
    Board of Directors Audit Committee Remuneration Committee Internal Audit Major Internal Policies
  • ESG
    Overview Sustainable Governance Environment Mangement Diversity, Equity & Inclusion Social Relationships Downloads
  • Investors
    Financials
    Financial Reports Operating Revenue
    Events
    Market Observation Post System
  • News
  • Careers
    Job Openings
  • Contact

繁體中文

News

  • 2020-06-10

    晟德公佈2020年5月合併財務報告

  • 2020-06-02

    晟德集團轉投資公司加科思敲定重量級新藥國際授權 與艾伯維達成SHP2抑制劑的全球戰略合作協議

  • 2020-05-27

    【代轉發】林榮錦對高等法院2020.05.27判決結果的聲明 - 雨再大,終究盼到天晴

  • 2020-05-21

    跨足美國資本市場 晟德集團國際佈局再下一城

  • 2020-05-13

    晟德公佈2020年第一季合併財務報告

  • 2020-05-13

    晟德轉投資公司澳優乳業發佈2020年第一季財務報告

  • 2020-05-05

    晟德(4123)糖尿病新藥CS02完成二期臨床最後受試者訪視(LPLV)

  • 2020-05-04

    航向未來產業 晟德(4123)投資水木易德投資基金有成

  • 2020-04-27

    晟德轉投資公司澳優乳業發佈2020年第一季盈利預告

  • 2020-04-21

    晟德轉投資公司東曜藥業宣佈旗下重磅生物學名藥TAB008第三期臨床試驗結果達標

1 上一頁 8 9 10 11 12 下一頁 18

HEAD OFFICE
TEL:+886 2 2655-8680
FAX:+886 2 2655-8380
7F., No.3-2, Park St., Nangang Dist.,
Taipei City 115, Taiwan (R.O.C.)

  • About Our Story Honorary President Big Issue Team Consultants
  • Investment Stretagies Portfolio
    Pharmacetical
  • Corporate Governance Board of Directors Audit Committee Remuneration Committee Internal Audit Major Internal Policies
  • ESG Overview Sustainable Governance Environment Mangement Diversity, Equity & Inclusion Social Relationships Downloads
  • Investors Financial Reports Operating Revenue Events Market Observation Post System
  • News
    Careers Job Openings
    Contact
Copyright © 2018 Center Ventures All right reserved. Web Design By rIDEA